MARRONE BIO INNOVATIONS INC's ticker is MBII and the CUSIP is 57165B106. A total of 52 filers reported holding MARRONE BIO INNOVATIONS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $24,000 | +41.2% | 19,169 | +54.6% | 0.00% | – |
| Q3 2019 | $17,000 | 0.0% | 12,398 | +6.2% | 0.00% | – |
| Q2 2019 | $17,000 | -10.5% | 11,671 | -6.9% | 0.00% | – |
| Q1 2019 | $19,000 | -26.9% | 12,535 | -10.8% | 0.00% | – |
| Q2 2018 | $26,000 | -79.7% | 14,054 | -78.3% | 0.00% | – |
| Q2 2015 | $128,000 | +85.5% | 64,777 | +240.7% | 0.00% | – |
| Q4 2014 | $69,000 | – | 19,013 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARDSLEY ADVISORY PARTNERS LP | 10,323,247 | $16,425,000 | 2.21% |
| ICM ASSET MANAGEMENT INC/WA | 262,900 | $481,000 | 0.34% |
| WADDELL & REED FINANCIAL INC | 24,714,892 | $45,228,000 | 0.10% |
| THOMPSON DAVIS & CO., INC. | 10,000 | $18,000 | 0.04% |
| Whitegate Investment Counselors, Inc. | 15,000 | $27,000 | 0.01% |
| Tower Research Capital LLC (TRC) | 22,728 | $42,000 | 0.00% |
| PRIMECAP MANAGEMENT CO/CA/ | 2,625,600 | $4,805,000 | 0.00% |
| Allworth Financial LP | 10,766 | $20,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 78,906 | $144,000 | 0.00% |
| NORTHERN TRUST CORP | 524,475 | $959,000 | 0.00% |